Skip to content

Neutrophil extracellular trap induced changes in (RSV-infected) pediatric human airway epithelial (HAE) cultures.

Neutrophil extracellular trap induced changes in (RSV-infected) pediatric human airway epithelial (HAE) cultures. - NETs induced changes in pediatric HAE

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49719
Enrollment
20
Registered
2020-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratoir syncytieel virus bronchiolitis RSV-bronchiolitis

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: - Age between 2 and 24 months - No known pulmonary disease - Endotracheal intubation (for elective surgery) - No signs of infection (fever, temperature >38.5 C) and no respiratory symptoms (cough, wheeze, snotty) present at moment of intubation. - No reported respiratory symptoms in the last 7 days prior to surgery (cough, wheeze, snotty) - Informed consent obtained for both non-endoscopic cytobrushing and serological testing after confirmation of comprehension of the Dutch language.

Exclusion criteria

Exclusion criteria: - Age 24 months - Reported pulmonary disorder - Non-elective endotracheally intubation - Symptoms of a present or recent infection (T>38.5C in the last 7 days prior to surgery) or reported respiratory symptoms in the last 7 days prior to surgery - No consent.

Design outcomes

Primary

MeasureTime frame
We will use the collected cells to obtain pediatric HAE cultures. We will use these cultures as an ex vivo model to study NETs induced changes in the context of RSV infection of the pediatric airways. We will perform measurements on airway mucus (protein expression) and airway epithelial damage (necrosis, apoptosis, loss of differentiation, loss of barrier function, apoptotic gene expression, inflammation markers and inflammatory pathways).

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)